Ignite Creation Date:
2026-03-26 @ 3:19 PM
Ignite Modification Date:
2026-06-02 @ 6:06 PM
Study NCT ID:
NCT07478133
Status:
COMPLETED
Last Update Posted:
2026-03-17
First Post:
2026-03-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bioequivalence Study of Nalfurafine Hydrochloride Orally Disintegrating Tablets on Fasting and Fed in Humans
Sponsor:
Shandong New Time Pharmaceutical Co., LTD
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
NTP-NFLF-T-BEO1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None